Previous Close | 23.72 |
1-Year Change | 84.74% |
6-Months Change | 32.44% |
3-Months Change | 13.87% |
Moving Avg (50d) | 23.845 |
Moving Avg (200d) | 19.475 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.04B |
Beta (3-Years) | 2.08 |
Revenue Growth (ttm) | -0% |
Net Profit Margin (ttm) | -66.04% |
Return On Assets (ttm) | -24.87% |
EPS (ttm) | -2.37 |
PE Ratio (ttm) | -10.01 |
Dividend Yield | % |
Asset Description: | BioLife Solutions, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-09-16 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
23.246 | 22.534 | 22.06 | 21.348 | 20.162 | 18.976 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |